Anterix Inc.
ATEX
$36.55
-$0.65-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.93M | 5.93M | 5.92M | 6.03M | 5.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.93M | 5.93M | 5.92M | 6.03M | 5.90M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.93M | 5.93M | 5.92M | 6.03M | 5.90M |
| SG&A Expenses | 42.70M | 43.12M | 46.02M | 48.78M | 49.29M |
| Depreciation & Amortization | 437.00K | 475.00K | 493.00K | 548.00K | 663.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.66M | 48.13M | 51.62M | 55.06M | 56.84M |
| Operating Income | -41.73M | -42.21M | -45.70M | -49.03M | -50.94M |
| Income Before Tax | 85.21M | 101.34M | 27.75M | -9.48M | -28.90M |
| Income Tax Expenses | 3.88M | 5.70M | -1.59M | 1.89M | 1.09M |
| Earnings from Continuing Operations | 81.32 | 95.63 | 29.33 | -11.37 | -29.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.32M | 95.63M | 29.33M | -11.37M | -29.99M |
| EBIT | -41.73M | -42.21M | -45.70M | -49.03M | -50.94M |
| EBITDA | -41.29M | -41.73M | -45.20M | -48.49M | -50.28M |
| EPS Basic | 4.36 | 5.13 | 1.58 | -0.62 | -1.62 |
| Normalized Basic EPS | -1.34 | -1.36 | -1.47 | -1.58 | -1.63 |
| EPS Diluted | 4.35 | 5.11 | 1.56 | -0.63 | -1.63 |
| Normalized Diluted EPS | -1.34 | -1.35 | -1.46 | -1.57 | -1.62 |
| Average Basic Shares Outstanding | 74.57M | 74.50M | 74.40M | 74.26M | 74.17M |
| Average Diluted Shares Outstanding | 74.80M | 74.90M | 74.78M | 74.57M | 74.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |